Drug intelligence / Profile preview

TD-0025

Development stage
Phase 3
Lead developer
Vietstar Biomedical Research
Modality
Small Molecules
Administration
Oral
01

Overview

TD-0025 is a novel small-molecule drug developed primarily for the treatment of erectile dysfunction. It has also been referenced in the context of autoimmune diseases such as rheumatoid arthritis, though its main clinical development and trials have focused on urogenital indications. The drug has undergone phase 2/3 clinical studies comparing its efficacy to sildenafil citrate (Viagra) for erectile dysfunction. The mechanism of action is not explicitly detailed in public sources; however, as a small molecule intended for erectile dysfunction, it may act via pathways similar to phosphodiesterase type 5 (PDE5) inhibitors or other vasodilatory mechanisms. The compound was originally developed by Vietstar Biomedical Research[1][4][5][7].

Brand names
Rocket1hRocket-1hRocket 1h
Other names
TD-0025TD0025TD 0025Rocket1hRocket-1hRocket 1h

Beyond the preview

Go deeper on TD-0025.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TD-0025.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call